Published in J Pharmacol Exp Ther on October 01, 1965
An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl. Br J Pharmacol (1970) 1.57
Sympathetic nerve cell destruction in newborn mammals by 6-hydroxydopamine. Proc Natl Acad Sci U S A (1970) 1.53
A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Med (2011) 1.36
The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci (2011) 1.31
Pharmacological significance of biogenic amines in the lungs: 5-hydroxytryptamine. Br J Pharmacol (1970) 1.05
Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death. PLoS One (2012) 1.02
Parkinson's disease: Exit toxins, enter genetics. Prog Neurobiol (2009) 0.95
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One (2012) 0.85
Cardiac sympathetic denervation in 6-OHDA-treated nonhuman primates. PLoS One (2014) 0.81
Modeling and imaging cardiac sympathetic neurodegeneration in Parkinson's disease. Am J Nucl Med Mol Imaging (2014) 0.79
A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212). Br J Pharmacol (1978) 0.75
Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease. Behav Brain Res (2016) 0.75
Pharmacokinetics of methyldopa in man. J Pharmacol Exp Ther (1976) 1.10
Fenfluramine and brain serotonin. Ann N Y Acad Sci (1978) 1.01
Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland. Am J Public Health (1988) 0.99
Tetrabenazine-induced depletion of brain monoamines: characterization and interaction with selected antidepressants. Eur J Pharmacol (1984) 0.98
Investigations on the action and mechanism of action of diphenylhydantoin as an antagonist of tetrabenazine and reserpine. Arch Int Pharmacodyn Ther (1973) 0.96
Potentiation and inhbition of some central actions of L(-)-dopa by decarboxylase inhibitors. J Pharmacol Exp Ther (1970) 0.95
Aromatic amino acid decarboxylase inhibitors. Fed Proc (1971) 0.94
Pancreatic endocrine insufficiency in posttransplant cystinosis. Am J Dis Child (1987) 0.93
Yolk amprolium levels produced by giving chickens amprolium in feed or water. Poult Sci (1968) 0.92
Human metabolism of cyproheptadine. Drug Metab Dispos (1975) 0.91
Tetrabenazine-induced depletion of brain monoamines: mechanism by which desmethylimipramine protects cortical norepinephrine. Eur J Pharmacol (1984) 0.89
Fenfluramine: long-term reduction in brain serotonin (5-hydroxytryptamine). Eur J Pharmacol (1976) 0.87
Methyldopa and adrenergic nerve function. Pharmacol Rev (1966) 0.86
Displacement of norepinephrine from the rat heart by 14C-metaraminol. Biochem Pharmacol (1967) 0.84
Relative fitness of hematopoietic progenitors influences leukemia progression. Leukemia (2011) 0.83
Preclinical toxicological studies of carbidopa and combinations of carbidopa and levodopa. Toxicol Appl Pharmacol (1974) 0.82
4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo. Biochem Pharmacol (1971) 0.80
New metabolizable immunologic adjuvant for human use. 6. Disposition of radioactivity after administration of labelled vaccine to the rat. Proc Soc Exp Biol Med (1967) 0.80
[3H]L-657,743 (MK-912): a new, high affinity, selective radioligand for brain alpha 2-adrenoceptors. Life Sci (1989) 0.80
Preparation of some 10-[3-(dimethylamino)-1-propyl]-10H-pyrazino[2,3-b][1,4] benzothiazines as potential neuroleptics. J Med Chem (1983) 0.80
Identification of functional oxytocin receptors in lactating rat mammary gland in vitro. Eur J Pharmacol (1990) 0.78
Ontogenic changes and regulation of renal angiotensin II type 1 receptor gene expression during fetal and newborn life. Pediatr Res (1994) 0.77
High affinity binding of [3H]neurotensin of rat uterus. Peptides (1988) 0.76
Heterogeneity of [3H]neurotensin bindings: studies with dynorphin, L-156,903 and levocabastine. Brain Res (1988) 0.76
Comparison of the effects of recently developed alpha 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brain. Biochem Pharmacol (1985) 0.75
Synthesis, assignment of absolute configuration, and receptor binding studies relevant to the neuroleptic activities of a series of chiral 3-substituted cyproheptadine atropisomers. J Med Chem (1979) 0.75
Some biochemical and pharmacological actions of -methylphenylalanine. Biochem Pharmacol (1970) 0.75
A 5-hydroxytryptamine-like mode of anorectic action for 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212). Br J Pharmacol (1978) 0.75
Antihypertensive activity of metyrosine in spontaneously hypertensive rats and its enhancement by carbidopa. Clin Sci Mol Med Suppl (1978) 0.75
Biochemistry and pharmacology of methyldopa and some related structures. Adv Drug Res (1967) 0.75
(S)-norepinephrine in the tissues of mice and rats given racemic erythro-3,4-dihydroxyphenylserine (DOPS). Life Sci I (1972) 0.75
Synthesis and norepinephrine depleting activity of some metaraminol ethers. J Med Chem (1970) 0.75
A new way to seal glass plates for denaturing gradient gel electrophoresis. Biotechniques (1994) 0.75
Liver alcohol dehydrogenase inhibition by fatty acid amides, N-alkylformamides and monoalkylureas. Life Sci (1976) 0.75
Molecular studies of the fourth component of complement (C4) in glomerulonephritis. Semin Nephrol (1989) 0.75
Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine. J Pharmacol Exp Ther (1979) 0.75
Bradykinin agonist activity of a novel, potent oxytocin antagonist. Eur J Pharmacol (1991) 0.75
Accelerated recovery from immune-mediated thrombocytopenia with plasmapheresis. Am J Med (1985) 0.75
Increased concentrations of 3-methoxy-4-hydroxyphenylethyl-eneglycol and homovanillic acid in rat brain after treatment with BE-2254 ("HEAT"). J Pharm Pharmacol (1975) 0.75
Binding of (+)PHNO and other D2-dopamine agonists to D1-dopamine receptors labelled by [3H]SCH 23390. J Neural Transm (1987) 0.75
Developmental regulation of the alpha 1B-adrenoceptor in the sheep kidney. Pediatr Res (1993) 0.75
A possible urinary backflow to ceca revealed by studies on chicks with artificial anus and fed amprolium-C14 or thiamine-C14. Poult Sci (1967) 0.75
Biochemical mechanisms of drug action. Annu Rev Pharmacol (1967) 0.75
Interactions of taurine and beta-alanine with central nervous system neurotransmitter receptors. Life Sci (1980) 0.75
Alpha 1B-adrenergic receptors in rat renal microvessels. Kidney Int (1995) 0.75
The effect of alcohol upon "muscle pull" of mice. Arch Int Pharmacodyn Ther (1977) 0.75
Fenfluramine-induced enhancement of confinement motor activity: an indirect 5-hydroxytryptamine-like action? Neuropharmacology (1975) 0.75
The effect of the optical isomers of alpha-methyl-p-tyrosine upon brain and heart catecholamines in the mouse. Biochem Pharmacol (1966) 0.75
Inhibition of adrenal phenethanolamine N-methyltransferase by substituted benzimidazoles. J Med Chem (1970) 0.75
6-Chloro-2(1-piperazinyl) quinoxaline (CPQ): action on serotonin-induced behavioral responses and interactions with chloromethamphetamine and dimethyl-meta-tyramine. Arch Int Pharmacodyn Ther (1978) 0.75
Inhibition of the serotoninergic uptake system by MK-212 (6-chloro-2-[1-piperazinyl]-pyrazine) Pharmacol Res Commun (1978) 0.75
Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes. Eur J Pharmacol (1982) 0.75
Relation between molecular configuration and certain biological actions of alpha-methyldopamine and alpha-methyl-meta-tyramine and their beta-hydroxylated products alpha-methylnorepinephrine and metaraminol. Arch Int Pharmacodyn Ther (1968) 0.75
Some biochemical and pharmacological actions of (-) erythro-meta-(meta-chlorobenzyloxy)-2-(1-aminoethyl)-benzyl alcohol. A derivative of metaraminol. Biochem Pharmacol (1971) 0.75
E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Mutat (1997) 0.75
Interaction of 2-[beta-(4-hydroxyphenyl)ethylaminomethyl]tertralone (BE-2254: 'HEAT') with catecholamine receptors in rat brain membranes. J Pharm Pharmacol (1978) 0.75
In vitro pharmacological profile of a novel structural class of oxytocin antagonists. J Pharmacol Exp Ther (1991) 0.75
Synthesis and receptor binding studies relevant to the neuroleptic activities of some 1-methyl-4-piperidylidene-9-substituted-pyrrolo[2,1-b][3]benzazepine derivatives. J Med Chem (1983) 0.75